# Trade Mark Journal No.2026/026 26 June 2026

## WO0000001370923 (5)

Office of origin: Republic of Korea

Date of International Registration:19 April 2017
Date of designation in the UK: 27 April 2026

Class 5
  Pharmaceutical and veterinary preparations; drugs for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating dystonia; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for the treatment of pain; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for use in treating urogenital system diseases and conditions; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes; bacterial toxins, namely botulinum toxin; appetite suppressants for medical purposes; medicated lotions; ointments for pharmaceutical purposes; analgesics; pharmaceutical agents affecting peripheral nervous system; poisons; vaccines; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid; medical gels for activation of tissues (gels for hypodermic syringes for improving wrinkles); hyaluronic acid preparations for medical purposes (fillers for skin and soft tissue used for skin moisturizing and improving wrinkles); modified hyaluronic acid preparations for medical purposes (fillers for skin and soft tissue used for skin moisturizing and improving wrinkles); filler for dermatology; skin fillers; syringes for medical purposes (prefilled with pharmaceutical preparations in the nature of hyaluronic acid, modified hyaluronic acid, its derivatives or substances that have a similar effect to hyaluronic acid, for the treatment and management of skin and soft tissue or artificial prostheses).

HUGEL INC.

Representative: THEWAVE IP LAW FIRM, 6F, 602 Seolleung-ro, Gangnam-gu, Seoul, REPUBLIC OF KOREA